Use of microRNAs in directing therapy and evaluating treatment response in colorectal cancer
暂无分享,去创建一个
B. Garicochea | R. Pogue | G. P. de Carvalho | R. D. de Andrade | Silmara Cristiane da Silveira Andreoli | Nina Jardim Gasparini
[1] J. Stenvang,et al. High expression of microRNA‐625‐3p is associated with poor response to first‐line oxaliplatin based treatment of metastatic colorectal cancer , 2013, Molecular oncology.
[2] Jun Yu,et al. MicroRNA-18a Attenuates DNA Damage Repair through Suppressing the Expression of Ataxia Telangiectasia Mutated in Colorectal Cancer , 2013, PloS one.
[3] Xiaozhong Wang,et al. Mammalian hyperplastic discs homolog EDD regulates miRNA-mediated gene silencing. , 2011, Molecular cell.
[4] C. Croce,et al. Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. , 2010, Biochemical pharmacology.
[5] E. Sontheimer,et al. Origins and Mechanisms of miRNAs and siRNAs , 2009, Cell.
[6] George A Calin,et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. , 2008, JAMA.
[7] W. Filipowicz,et al. Post-transcriptional gene silencing by siRNAs and miRNAs. , 2005, Current opinion in structural biology.
[8] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.